Stock listing
Liminatus Pharma, Inc.
Selected listing: LIMN · NASDAQ · USD · US
Liminatus Pharma, Inc. (NASDAQ:LIMN), Health Technology. Latest release Sep 29, 2026: Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule.
- Ticker
- NASDAQ:LIMN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Liminatus Pharma, Inc.
Liminatus Pharma, Inc. is a public company traded under the ticker LIMN in the American market. Liminatus Pharma focuses on developing innovative pharmaceutical solutions.
Latest news from Liminatus Pharma, Inc.
Liminatus Pharma Regains Compliance with Nasdaq Minimum Bid Price Rule
September 28, 2026
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
August 24, 2026
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
August 18, 2026
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
August 13, 2026
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
June 3, 2026
Research Liminatus Pharma, Inc.
Liminatus Pharma, Inc. company profile
View the public company page for Liminatus Pharma, Inc. on 6ix.
Liminatus Pharma, Inc. news
Read company news and market updates connected to Liminatus Pharma, Inc..
Liminatus Pharma, Inc. investor events
Find investor webinars, events, and replay context for Liminatus Pharma, Inc..